Agarwal AK, Raja A, Brown BD (2023) Chronic Obstructive Pulmonary Disease. In: StatPearls [Internet]. StatPearls Publishing Copyright ©2024, Treasure Island (FL): StatPearls Publishing; Bookshelf ID: NBK559281. https://www.ncbi.nlm.nih.gov/books/NBK559281/

Christenson SA, Smith BM, Bafadhel M, Putcha N (2022) Chronic obstructive pulmonary disease. Lancet 399:2227–2242. https://doi.org/10.1016/S0140-6736(22)00470-6

Article  PubMed  Google Scholar 

Disease GBD, Injury I, Prevalence C (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1545–1602. https://doi.org/10.1016/S0140-6736(16)31678-6

Article  Google Scholar 

Boukhenouna S, Wilson MA, Bahmed K, Kosmider B (2018) Reactive oxygen species in chronic obstructive pulmonary disease. Oxid Med Cell Longev 2018:5730395. https://doi.org/10.1155/2018/5730395

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brightling C, Greening N (2019) Airway inflammation in COPD: progress to precision medicine. Eur Respir J 54(2):1900651. https://doi.org/10.1183/13993003.00651-2019

Vanhamme L, Zouaoui Boudjeltia K, Van Antwerpen P, Delporte C (2018) The other myeloperoxidase: emerging functions. Arch Biochem Biophys 649:1–14. https://doi.org/10.1016/j.abb.2018.03.037

Article  CAS  PubMed  Google Scholar 

Finicelli M, Digilio FA, Galderisi U, Peluso G (2022) The emerging role of macrophages in chronic obstructive pulmonary disease: the potential impact of oxidative stress and extracellular vesicle on macrophage polarization and function. Antioxidants (Basel) 11(3):464. https://doi.org/10.3390/antiox11030464

Guo P, Li R, Piao TH, Wang CL, Wu XL, Cai HY (2022) Pathological mechanism and targeted drugs of COPD. Int J Chron Obstruct Pulmon Dis 17:1565–1575. https://doi.org/10.2147/COPD.S366126

Article  CAS  PubMed  PubMed Central  Google Scholar 

Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, Fitzgerald M, Barnes PJ (2002) Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 283:L867–873. https://doi.org/10.1152/ajplung.00020.2002

Article  CAS  PubMed  Google Scholar 

Wallace AM, Sandford AJ, English JC, Burkett KM, Li H, Finley RJ, Muller NL, Coxson HO, Pare PD, Abboud RT (2008) Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema. COPD 5:13–23. https://doi.org/10.1080/15412550701817789

Article  PubMed  Google Scholar 

Gharib SA, Manicone AM, Parks WC (2018) Matrix metalloproteinases in emphysema. Matrix Biol 73:34–51. https://doi.org/10.1016/j.matbio.2018.01.018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alharbi KS, Fuloria NK, Fuloria S, Rahman SB, Al-Malki WH, Javed Shaikh MA, Thangavelu L, Singh SK, Rama Raju Allam VS, Jha NK et al (2021) Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact 345:109568. https://doi.org/10.1016/j.cbi.2021.109568

Article  CAS  PubMed  Google Scholar 

DIS A, Gnemmi I, Dossena F, Ricciardolo FL, Maniscalco M, Lo Bello F, Balbi B (2022) Pathogenesis of COPD at the cellular and molecular level. Minerva Med 113:405–423. https://doi.org/10.23736/S0026-4806.22.07927-7

Article  Google Scholar 

Zhang MY, Jiang YX, Yang YC, Liu JY, Huo C, Ji XL, Qu YQ (2021) Cigarette smoke extract induces pyroptosis in human bronchial epithelial cells through the ROS/NLRP3/caspase-1 pathway. Life Sci 269:119090. https://doi.org/10.1016/j.lfs.2021.119090

Article  CAS  PubMed  Google Scholar 

Uwagboe I, Adcock IM, Lo Bello F, Caramori G, Mumby S (2022) New drugs under development for COPD. Minerva Med 113:471–496. https://doi.org/10.23736/S0026-4806.22.08024-7

Article  PubMed  Google Scholar 

Lakshmi SP, Reddy AT, Reddy RC (2017) Emerging pharmaceutical therapies for COPD. Int J Chron Obstruct Pulmon Dis 12:2141–2156. https://doi.org/10.2147/copd.S121416

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang M, Hei R, Zhou Z, Xiao W, Liu X, Chen Y (2023) Macrophage polarization involved the inflammation of chronic obstructive pulmonary disease by S1P/HDAC1 signaling. Am J Cancer Res 13:4478–4489

CAS  PubMed  PubMed Central  Google Scholar 

Sharma P, Karnam K, Mahale A, Sedmaki K, Krishna Venuganti V, Kulkarni OP (2022) HDAC5 RNA interference ameliorates acute renal injury by upregulating KLF2 and inhibiting NALP3 expression in a mouse model of oxalate nephropathy. Int Immunopharmacol 112:109264. https://doi.org/10.1016/j.intimp.2022.109264

Article  CAS  PubMed  Google Scholar 

Leus NG, Zwinderman MR, Dekker FJ (2016) Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-kappaB-mediated inflammation. Curr Opin Chem Biol 33:160–168. https://doi.org/10.1016/j.cbpa.2016.06.019

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao Y, Ma G, Yang X (2019) HDAC5 promotes Mycoplasma pneumoniae-induced inflammation in macrophages through NF-kappaB activation. Life Sci 221:13–19. https://doi.org/10.1016/j.lfs.2019.02.004

Article  CAS  PubMed  Google Scholar 

Poralla L, Stroh T, Erben U, Sittig M, Liebig S, Siegmund B, Glauben R (2015) Histone deacetylase 5 regulates the inflammatory response of macrophages. J Cell Mol Med 19:2162–2171. https://doi.org/10.1111/jcmm.12595

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li B, Zhang L, Zhu L, Cao Y, Dou Z, Yu Q (2021) HDAC5 promotes intestinal sepsis via the Ghrelin/E2F1/NF-kappaB axis. FASEB J 35:e21368. https://doi.org/10.1096/fj.202001584R

Article  CAS  PubMed  Google Scholar 

Jiang Z, Tan J, Yuan Y, Shen J, Chen Y (2022) Semaglutide ameliorates lipopolysaccharide-induced acute lung injury through inhibiting HDAC5-mediated activation of NF-kappaB signaling pathway. Hum Exp Toxicol 41:9603271221125932. https://doi.org/10.1177/09603271221125931

Article  CAS  PubMed  Google Scholar 

Bockstiegel J, Wurnig SL, Engelhardt J, Enns J, Hansen FK, Weindl G (2023) Pharmacological inhibition of HDAC6 suppresses NLRP3 inflammasome-mediated IL-1beta release. Biochem Pharmacol 215:115693. https://doi.org/10.1016/j.bcp.2023.115693

Article  CAS  PubMed  Google Scholar 

Sedmaki K, Karnam K, Sharma P, Mahale A, Routholla G, Ghosh B, Prakash Kulkarni O (2022) HDAC6 inhibition attenuates renal injury by reducing IL-1beta secretion and RIP kinase mediated necroptosis in acute oxalate nephropathy. Int Immunopharmacol 110:108919. https://doi.org/10.1016/j.intimp.2022.108919

Article  CAS  PubMed  Google Scholar 

Ren Y, Su X, Kong L, Li M, Zhao X, Yu N, Kang J (2016) Therapeutic effects of histone deacetylase inhibitors in a murine asthma model. Inflamm Res 65:995–1008. https://doi.org/10.1007/s00011-016-0984-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costantini C, Bellet MM, Renga G, Stincardini C, Borghi M, Pariano M, Cellini B, Keller N, Romani L, Zelante T (2020) Tryptophan co-metabolism at the host-pathogen interface. Front Immunol 11:67. https://doi.org/10.3389/fimmu.2020.00067

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zelante T, Puccetti M, Giovagnoli S, Romani L (2021) Regulation of host physiology and immunity by microbial indole-3-aldehyde. Curr Opin Immunol 70:27–32. https://doi.org/10.1016/j.coi.2020.12.004

Article  CAS  PubMed  Google Scholar 

Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, Zecchi R, D’Angelo C, Massi-Benedetti C, Fallarino F et al (2013) Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39:372–385. https://doi.org/10.1016/j.immuni.2013.08.003

Article  CAS  PubMed  Google Scholar 

Liu M, Wang Y, Xiang H, Guo M, Li S, Liu M, Yao J (2023) The tryptophan metabolite indole-3-carboxaldehyde alleviates mice with DSS-induced ulcerative colitis by balancing amino acid metabolism, inhibiting intestinal inflammation, and improving intestinal barrier function. Molecules 28(9):3704. https://doi.org/10.3390/molecules28093704